抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性
评价者：陈茜1, 周建英1, 文献合成者：黎扬斯2

Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Reviewers： CHEN Xi1, ZHOU Jian-ying1, Literature Co-worker： LI Yang-si2